Delivery Order SPE2DB25D3306-SPE2DB25FUCMS
- Not listed
- The Defense Logistics Agency awarded a $1,917.01 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with a completion date of August 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,979.12 on September 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $11,418.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside award was competitively procured and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,471 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency awarded a delivery order valued at $28,607.13 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180 count) on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $16,961.57 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this contract. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,214.04 firm fixed price delivery order for Entresto 24 mg-26 mg tablets (60-count) on July 29, 2025, with completion scheduled for July 30, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCMSDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly supplies the Defense Logistics Agency and Defense Health Agency with a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's federal contract history demonstrates consistent capability in delivering both brand-name and generic medications through competitive procurement processes. This delivery order for Entresto, a cardiac medication, exemplifies the routine pharmaceutical supply fulfillments AmerisourceBergen executes to support military and veteran healthcare systems across the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/4/25 |